000 01480 a2200385 4500
005 20250513231128.0
264 0 _c20010510
008 200105s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.45.3.966-968.2001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeig, M
245 0 0 _aSynergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cMar 2001
300 _a966-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAIDS-Related Opportunistic Infections
_xmicrobiology
650 0 4 _aAntifungal Agents
_xpharmacology
650 0 4 _aCandida albicans
_xdrug effects
650 0 4 _aCandidiasis
_xmicrobiology
650 0 4 _aDrug Resistance, Microbial
_xphysiology
650 0 4 _aDrug Synergism
650 0 4 _aHIV Infections
_xmicrobiology
650 0 4 _aHumans
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aNaphthalenes
_xpharmacology
650 0 4 _aPharyngitis
_xmicrobiology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aTerbinafine
650 0 4 _aTriazoles
_xpharmacology
650 0 4 _aVoriconazole
700 1 _aMüller, F M
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 45
_gno. 3
_gp. 966-8
856 4 0 _uhttps://doi.org/10.1128/AAC.45.3.966-968.2001
_zAvailable from publisher's website
999 _c11119650
_d11119650